Warfarin is an anticoagulant medication used to prevent blood clots in people who are at risk of heart attack, stroke, or other serious health problems.
The U.S. Food and Drug Administration (FDA) announced the voluntary recall of Jantoven Warfarin Sodium tablets (manufactured by Upsher-Smith Laboratories). The company is initiating the recall as a precautionary measure after a single bottle labeled as 3 milligram tablets was found to contain tablets at a higher, 10 milligram strength. To date, the company has identified no additional mislabeled bottles.
Still, this is a potentially serious problem. People who take an inappropriately high dose could experience a life-threatening hemorrhage.
If you take Jantoven Warfarin, examine your medications. The two tablets can be readily identified by color: the 3 mg tablet is tan, whereas the 10 mg tablet is white. In addition, the 3 mg tablet is imprinted with the letters WRF, a line, and the number 3 below the line. The reverse side of the 3 mg tablet carries the number 832. The 10 mg tablet is imprinted with the letters WRF, a line, and the number 10 below the line. The reverse side of the 10 mg tablet carries the number 832.
If you believe you were given the wrong medication, or if you have questions about whether your medication has been recalled, call the Upsher-Smith medical information line at 1-888-650-3789 for more information and to access product details, Monday-Friday between 8:00 a.m. and 5:00 p.m. (CST).
